At a glance
ClinicalIndex Comparison RecordN/ARecruiting· 320 target
Drug / intervention
peripheral blood collectionprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT04088422N/ARecruitingUpdate OverdueUpdated 40mo ago · Completion was 18mo agoEnrollment Stalled
Long Recruiting
Update Overdue
Prospective, Observational Study on Cell Free DNA Genotyping as a Tool to Inform Mature B-cell Lymphoma Management
In Brief
An observational study evaluating peripheral blood collection for Mature B-Cell Lymphoma. Currently recruiting, targeting 320 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
The purpose of this study is to assess whether plasma cell free DNA is an accurate tool that can early and dynamically inform on treatment outcome and an accessible source of tumor DNA to track tumor clonal evolution.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsMature B-Cell Lymphoma
CountriesChina
Collaborators--
Timeline
N/ARecruiting
20202021202220232024202520262027
First PostedSep 2019
Enrollment StartSep 2022
Primary CompletionDec 2024
TodayJul 2026
Study CompletionDec 2026
First PostedSep 12, 2019
Enrollment StartSep 28, 2022
Primary CompletionDec 1, 2024
Study CompletionDec 1, 2026
TodayJul 1, 2026
Enrollment to primary: 2.2 yearsPosted 6.8 years ago
Interventions
peripheral blood collectionprocedure
peripheral blood collection at treatment start, interm PET/CT, end of treatment PET/CT, one-year and two-year follow-up and or progression or relapse